Your browser doesn't support javascript.
loading
Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome.
Pallenberg, Sophia T; Pust, Marie-Madlen; Rosenboom, Ilona; Hansen, Gesine; Wiehlmann, Lutz; Dittrich, Anna-Maria; Tümmler, Burkhard.
Afiliación
  • Pallenberg ST; Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical Schoolgrid.10423.34, Hannover, Germany.
  • Pust MM; German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Hannover Medical Schoolgrid.10423.34, Hannover, Germany.
  • Rosenboom I; Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical Schoolgrid.10423.34, Hannover, Germany.
  • Hansen G; German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Hannover Medical Schoolgrid.10423.34, Hannover, Germany.
  • Wiehlmann L; Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical Schoolgrid.10423.34, Hannover, Germany.
  • Dittrich AM; Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical Schoolgrid.10423.34, Hannover, Germany.
  • Tümmler B; German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Hannover Medical Schoolgrid.10423.34, Hannover, Germany.
Microbiol Spectr ; 10(5): e0145422, 2022 10 26.
Article en En | MEDLINE | ID: mdl-36154176

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulador de Conductancia de Transmembrana de Fibrosis Quística / Fibrosis Quística Idioma: En Revista: Microbiol Spectr Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Regulador de Conductancia de Transmembrana de Fibrosis Quística / Fibrosis Quística Idioma: En Revista: Microbiol Spectr Año: 2022 Tipo del documento: Article